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to test the hypothesis that subjects with TAO have a greater degree of tobacco depen- 
dence than do control subjects with coronary atherosclerosis (CAD). 
Methods: Subjects with TAO (n = 218, confirmed by angiography, biopsy, or noninvasive 
arterial testing) or CAD (n=343, diagnosed by coronary angiography) were mailed a stan- 
dardized questionnaire regarding tobacco use, to which 103 and 273 responded, raspec- 
tively. Degree of tobacco dependence in each group was ascertained by several 
methods, including the Fagerstrtim Test for Nicotine Dependence Questionnaire. 
Resuks: The TAO group was younger at Index date (year of first diagnosis for TAO 
patients, year of PTCA for CAD patients) (TAO 37.6e9.0 vs CAD 43.3+4.9 yrs, P<.OOOl), 
but the groups did not differ in age at first tobacco exposure (TAO 16.7k3.1 vs CAD 
17.3k4.2 yrs, p=.67), current tobacco use at time of survey (TAO 54% vs CAD 46%, 
p=.17). or Fagerstrbm score (TAO 4.7t2.3 vs CAD 5.1~2.3, p=.24). Kaplan Meier curves 
showed no significant difference in time lo stopping tobacco use after first diagnosis 
(p=.798). TAO subjects smoked fewer cigarettes per day than CAD subjects (TAO 
22.3*10.7 vs CAD 27.7k15.3 cigarettes/day, p=.OO3). However, among current smokers 
(n=l53). the groups did not seem lo differ in number of cigarettes/day (19.6+7.9 vs. 
22.5+11 .l, p=.20). Individuals in the TAO group appeared to be more likely to have made 
a serious attempt to quit smoking than those in the CAD group (TAO 97%% vs CAD 
90%, p=O.O5). 
Conclusions: In contrast to case reports of extreme tobacco dependence in the TAO pop- 
ulation, the degree of tobacco dependence in subjects with TAO is similar to matched 
subjects with CAD. 
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1200-l 34 Low Bone Mineral Density Predicts Significant 
Coronary Artery Disease at Cardiac Catheterization 
Hillarv H. Traq Christine Z. Dickmson, Judith A. Boura, William W. ONeill, Pamela A. 
Marcovitz, William Beaumont Hospital, Royal Oak, MI 
Background: Osteoporosis and coronary disease (CAD) share several risk factors (age, 
diabetes, hyperlenslon [HTN], and smoking) and may be related. The purpose of this 
study is lo investigate whether osteoporosis is predictive of significant CAD compared 
with traditional risk factors. 
Methods: Dual energy x-rays absorp~iometry (DEXA) scan and cardiac cathererization 
were performed on 209 patients (163 females, 26 males) between l/2000 and 712002. 
DEXA scans were classified into 3 groups: normal, osteopenia, and osteoporosis based 
on World Health Organization criteria. Angiograms were classified as having significant 
CAD if 2 50% luminal stenosis was noted in a major coronary artery. Clinical variables 
(age, HTN, diabetes, smoking, family history of CAD, hyperlipidemia) were examined. 
Results: 117 patients had significant CAD. Patients with and without CAD were similar 
clinically and demographically. Unlvariate predictors of CAD ware osteoporosis, diabe- 
tes, hypertension, and family history of premature CAD (table). On multivariate analysts, 
odds ratio (OR) for CAD was highest for osteoporosis: O&5.0 (95% confidence interval, 
2.25-l 1 .l [PC O.OOOl]). 
Conclusion: The presence of osteoporosis predicts significant coronary stenosis with 
higher odds ratio than traditional risk factors. Our study is the flrsst to report an increase in 
documented CAD in patlents with osteoporosis. 
Variable Odds ratio 95% confidence interval P- value 
Osteoporosis 5 2.25 - 11.1 co.ooo1 
Hypertension 2.37 1.04 - 5.4 0.041 
Family history of premature CAD 2.79 1.26-6.18 0.012 
Diabetes mellitus 3.3 1.6 6.79 0.0012 
1200-135 Rheumatoid Arthritis Is Not Associated With Myocardial 
Infarction After Controlling for Other Risk Factors 
Jefferson T. Baer, Jesse A. Berlin, Daniel A. Albert, Stephen E. Kimmel, Universtty of 
Pennsylvania, Philadelphia, PA 
Background: Previous studies have suggested that patients with rheumatoid arthritis 
(RA) have an increased rate of cardiovascular death and myocardial infarction (Ml) com- 
pared to Ihe general population. However, the majority of these studies failed to control 
for known cardiac nsk factors, some of which appear to be more common in patients with 
RA. 
Methods: A case-control study of first MI. ages 40 through 75, was conducted among 36 
hospitals in a B-county area during a 3.year period. Cases were patients hospitalized 
with a first nonfatal MI, and controls ware randomly selected from the same geographic 
area. Self-report of physician diagnosed RA was collected via telephone Interviews, 
along with detailed information regardmg cardiac risk factors and current medications 
using state-of-the-art methods. Multivariable logistic regression was used to adjust for 
age, sex, race, hormone replacement therapy, body mass index (BMI), cigarette smok- 
ing, insurance, exercise, income, education, history of coronary disease, family history, 
hypertension (HTN), diabetes mellitus (DM), hyperlipidemia, nonsteroidal anti-inflamma- 
tory drug use, aspirin use, disease-modifying anti-rheumatic drug use, and number of 
doctor visits. 
Results: 1078 cases (4.74% with RA) and 4255 controls (3.62% with RA) were inter- 
wewed. There was an increased risk of myocardial mfarction (MI) in patients with RA in 
the unadjusted model (OR 1.42, 95% Cl: 1.02-l .97). However, after adjusting for con- 
founding, there was no increased risk from RA (OR 0.86, 95% Cl: 0.58-1.29). The vari- 
ables responsible for confounding were age, HTN, DM, BMI, history of coronary disease. 
education and number of doctor visits. There were no subgroups at mcreased risk of Ml 
from RA. 
Conclusions: Previous studies showing an increased risk of cardiovascular death III 
patients with RA did not control for known cardiac risk factors. The current study showed 
an increased risk of MI in patients with RA that was solely explained by RA patients’ 
greater prevalence of several rksk factors. Physicians should aggressively screen for and 
modify common cardiac risk factors in patients with RA. 
1200-l 36 Green Tea Derived Polyphenol Antioxidant, EGCG, 
Differentially Modulates Developing Compared to 
Mature Atherosclerotic Lesions in Apo E -/- Mice 
Stephanie M. Babbidqg, Xiaonmg Zhao. Ramprasad Dandillaya, Juliana Yano, Paul C. 
Dimayuga, Bojan Cercek, Prediman K. Shah, Kuang-Yuh Chyu, Cedars-Sinai Medical 
Center, Los Angeles, CA 
Background: Atherosclerosis starts at a young age, but therapy IS generally begun 
when the disease is well established. Therapy such as green tea derived polyphenol anti- 
oxidant epigallocatechm gallate (EGCG) may be more effective when applied during the 
developing rather than established phase of atherosclerosis. 
Hypothesis: Developing atherosclerotic lesions are differentially modulated by anti-oxi- 
dant therapy compared lo mature atherosclerotic lesions. 
Methods: Newly developing atherosclerotic lesions were Induced by placing a carotid 
cuff in apoE (-i-) hypercholesterolemic mice at 26 weeks of age. EGCG (10 mgikg, n=7) 
or PBS (n=7) was injected i.p. daily. Sections of cuffed arteries ware stained for PCNA. 
H&E and oil-red-O. Aortic sinus plaques from the same animals were stained for collagen 
content and macrophage. Plasma cholesterol and antioxidant potential were also mea- 
sured. 
Results: Newly developed lipid-rich atheroma in the carotid artery were smaller in the 
EGCG group compared to the PBS group 21 days after cuffing. EGCG treatment 
reduced medial PCNA expression 3 days after cuffing (Table). Mature aortic sinus 
plaques were not affected by EGCG (Table). BW and cholesterol levels were compara- 
ble in both groups. EGCG level 1 hour after injection was 138 * 44 ng/mL (n=5). 
Conclusion: Our data suggest that antioxidant therapy inhibits the formation of develop- 
ing, but not mature plaques. This observation implies timing of ant&dam therapy may 
be critical for antlatherogenic effect. 
Gr Carotid Carotid Sinus Sinus Plaque Sinus Plasma 
o” PCNA plaque Size Plaque Macrophage Plaque antioxidant 
P (day 3) (mm2, Size (mn?) (%) Collagen level# 
(%) 
E 7.4i6.2* 0.014iO.008 0.899&0.16 14.6k2.8 4O.lk6.6 1.147 * 
G (37 * 0.579* 
C sections) 
G 
P 11.9i10.7 0.031~0.013 0.851*0.16 17.2+4.6 
B (25 
S sections) 
42.5k3.2 0.262 f 
0.290 
meankstd; *p < 0.05 vs. PBS group; #mM uric acid equivalents 
1200-137 Downregulation of Microfilament Expression in 
Atherosclerotic Plaque Is Mediated bv Oxidized Low- 
Density Lipoprotein’ 
Koichi Ono Tao Peng, Jie Du, Yusuke Higashi. Yoshifumi Okura, Hiroyuki Itabe, Arkady -I 
Goubine. PatrIce Delafontaine, The University of Kansas Medical Center, Kansas City, 
KS 
The cellular microfilament system is a highly dynamic network comprised of multiple pro- 
teins that are essential for cell motility, contraction, cell-cell and cell-substrate interac- 
tions, signalmg pathways, gene expression and cell differentiation. To examine the 
regulation of Vascular Smooth Muscle Cell (VSMC) mvxofilaments in atherosclerotic 
plaque development we performed immunostaining fora-, p-actin and wmentm in human 
femoral and carotid atherosclerotic plaques (n=20). There was a marked reduction in a- 
actin and vimentin expression in VSMC in advanced plaque. To identify stimuli that 
downregulate microfilament components in plaque, we incubated human VSMC with O- 
100 uglml Oxidized LDL (OxLDL), an important proatherogenic molecule, or o-100 us/ml 
native LDL (nLDL) and measured cytoskeletal protein expression by western immunob- 
lotting. OxLDL, but not nLDL, dose dependently reduceda-actin and vimentin expression 
(21 r 5%, n=8. pc.05, and 52 * 6%. n=19. pcO.0001, respectively, with 100 ug/ml 
OxLDL) and non-significantly increased p-&in expresston. To determine intracellular 
signaling pathways mediating OxLDL effects on microfilaments we studied the effect of 
candidate proteins implicated in OxLDL stgnalmg. OxLDL components are high-affinity 
liaands for the PPARvnuclear recer&r. but the effect of OxLDL was not blocked bv the 
P>ARy inhibitor, PGF; a, 200 nM, and the synthetic PPARy lkgand ciglitazone (0.1O’uM) 
did not reaulate vimentm or a-actin exmesslon. Furthermore. inhibition of the ~38 MAPK 
pathway (88203580, 10 uM) did not modify OxLDL effects, Indicating that the ability of 
OxLDL to regulate vlmentinla-actln was not mediated via a p38 MAPK dependent path- 
way. In conclusion: 
306A ABSTRACTS - Vascular Disease, Hypertension, and Prevention JACC March 19,2003 
1. There is a dramatic downregulation of a-actin and vimentin microfilaments in athero- 
sclerotic plaque. 
2. OxLDL markedly downregulates VSMC a-actin and vimentin expression via a PPARy 
and ~38 MAPK Independent pathway. OxLDL regulation of VSMC cytoskeletal pro- 
teins may play a critical role in afherogenesis through alterations In cell motility, differ- 
entiation and growth. 
1200-l 38 Intravascular Detection of lnflammed Atherosclerotic 
Plaques With a Novel Macrophage-Targeted 
Fluorescent Photodynamic Compound 
Ahmed Tawakol, Alan Fischman, Henry Gewirtz, James E. Muller, Thomas Brady, 
Michael Hamblin, Mass General Hospital, Boston, MA 
Background: Vulnerable plaques contain abundant macrophages. We developed a 
novel photodynamic agent, chlorin, conjugated with maleylated albumin, (ce6-mal-alb) 
that concentrates in macrophage-rich plaques and has a high fluorescent yield. As such, 
we tested hypothesis that experimental atherosclerotic lesions (ATHERO) can be 
detected using ce6-mal-alb and an intravascular fluorescence spectroscopy catheter. 
Methods: ATHERO were induced in New Zealand rabbits by infradiaphragmatic aortic 
balloon-injury followed by high cholesterol diet. At IO weeks, ce6-mal-alb was adminis- 
tered to 7 atherosclerotic and 7 control animals. 24 hours later, aortic uptake of the ce6- 
mal-alb uptake was measured in situ, using an intravascular fluorescence spectroscopy 
catheter. Thereafter, the aortas were excised and dissolved in NaOH/SDS for spectroflu- 
orimetric determination of ce6 content. 
Results: Intravascular measurements of ce6-mal-alb fluorescence were higher in 
ATHERO vs. non-athero segments, (8.8i4.8 vs. 2.2k2.2 X103AU, P<O.OOl, figure). Fur- 
ther, ce6-mal-alb concentration was higher within the ATHERO aortas (5.2t3.2 vs. 
1.9+1.2, ce6 fluorescencelgm tissue x IOs, p=<O.Ol). Conclusion: CeG-mal-alb can be 
employed for intravascular characterization of atherosclerotic plaques. Because this 
novel PDT compound is selectively toxic to macrophages when light-activated, this agent 
may be useful for both the detection and therapeutic modification of macrophage-rich 
plaques. 
Intravascular Meas;urement of 
ceii-mabalb LIptake 
10-i T 
1200-l 39 Endogenous Free Radical Generating Sources Are 
Involved in Smoking-Mediated Dysfunction of Nitric 
Oxide Biosynthesis in Human Coronary Artery 
Endothelial Cells: An In Vitro Demonstration 
Sudhesh K. Srivastava, Rajat S. Barua, Dhanonjoy C. Saha, Lesley-Jane Eales- 
Reynolds, Mary C. DeVoe, John A. Ambrose, Saint Vincent Catholic Medical Centers of 
New York, New York, NY, School of Biomedical and Life Sciences, University of Surrey, 
Guildford, United Kingdom 
Backgromd We have previously demonstrated that cigarette smoking alters NO bio- 
synthesis by reducing NO availability and eNOS activity while increasing eNOS protein 
expression. Although oxidative stress has been proposed as the leading mechanism for 
these changes, the source of free radicals is unclear. Cigarette smoke contains high lev- 
els of free radicals. However, free radicals potentially arise from endogenous sources as 
well. This study investigated the role of endogenous free radical generating sources in 
smoking-related dysfunctional NO biosynthesis in human coronary artery endothelial 
cells (HCAECs). 
Methods and Results Confluent (-85%) monolayers of HCAECs were incubated with 
serum from 6 nonsmokers and 8 smokers for 12 hours with or without the addition of 
either IOOuM LNMMA, 30uM apocyamn (NADPH oxidase inhibitor), 1OOuM allopurinol 
(xanthine oxidase inhlbitor) or 2uM rotenone lmitochondrial electron transporl chain 
(METC) inhibitor]. Following incubation, NO levels and eNOS protein expression were 
measured from the same culture by standard techniques. HCAECs incubated with smok- 
ers’ serum alone showed significantly lower NO level (O.OZ+O.Olversus 0.13*0.02 uM/pg 
eNOS/mg total protein, P<O.O07) and higher eNOS expression (P<O.OOS) compared to 
nonsmokers. In smokers, only allopurinol (0.04*0.01 uM/pg eNOS/mg total protein) or 
rotenone (0.06*0.01 uM/pg eNOS/mg total protein) treatment significantly +0.05) 
improved NO availabillty. However, levels were still lower compared to nonsmokers 
(P<O.O5). Interestingly, when smokers’ serum was treated with combined rotenone. 
allopurinol and 20uM tetrahydrobiopterin (an eNOS cofactor) the NO level, eNOS 
expression and eNOS activity normalized to that of nonsmokers. 
Conclusions To our knowledge this is the first demonstration that endogenous free 
radical generators such as xanthine oxidase, the METC and eNOS contribute to smok- 
ing-mediated dysfunction of NO biosynthesis. 
1200-140 Synergistic Effect of Urotensin II With Serotonin on 
Vascular Smooth Muscle Cell Proliferation 
Takuva Watanabe, Takashi Katagiri, Rajbabu Pakala, Claude R. Benedict, Showa 
University School of Medicine, Tokyo, Japan, University of Texas-Houston Medical 
School, Houston, TX 
Background: Urotensin II (U-II), the most potent vasoconstrictor known to date, and sero- 
tonin (5-HT) have been recently shown to play an important role in pulmonary hyperten- 
sion. However, little is known about the effect of U-II and its interaction with 5.HT on 
vascular smooth muscle cell (VSMC) proliferation. We assessed the interaction between 
U-II and 5.HT in inducing VSMC proliferation. 
Methods: Growth-arrested rabbit VSMCs were incubated in serum-free medium with dif- 
ferent concentrations of U-II and 5-HT. VSMC proliferation was examined by the 
increase in [SHlthymidine incorporation into cellular DNA and cell number. 
Results: U-II or 5.HT induced [3H]thymidlne incorporation in a concentration-dependent 
manner with a maximal effect at a concentration of 50 nanoM (I 61%) or 50 microM 
(205%), respectively. When added together, low concentrations of U-II (50 nanoM) and 
5-HT (1 microM) interacted synergistically in inducing [SH]thymidine incorporation 
(382%). These effects on [SH]thymidine incorporatlon were paralleled by an increase in 
cell number. The G-protein inactivator GDP-beta-S (100 microM), protein kinase C (PKC) 
inhibitor Ro31-8220 (0.1 microM), c-Src tyrosine kinase inhibitor PP2 (I microM), and 
mitogen-activated protein kinase (MAPK) kinase inhibitor PD098059 (IO microM) signifi- 
cantly inhibited the mitogenic effects of U-II and 5-HT and also their interaction in induc- 
ing [3H]thymidine incorporabon. 
Conclusion: Our results suggest that U-II and 5-HT may induce the synergistic interaction 
in inducing VSMC proliferation via a G-protein-coupled receptor/PKClc-Src tyrosine 
klnase/MAPK pathway, thtis contributing to the relatively rapid development of athero- 
sclerosis in hypertensive vascular disease. 
1200-141 Systemic Inflammation: Independent Predictor of 
Contrast Induced Nephropathy 
Harish R. Chandra, Peter Kim, James A. Goldstein, Mehrdad H. Sadeghi, William W. 
O’Neill, William Beaumont Hospital, Royal Oak, MI 
Background: Recent observations demonstrate that systemic inflammation may exert 
adverse influence throughout the vascular bed. This study was designed to determine 
whether there is a relationship between the presence and magnitude of systemic inflam- 
mation and contrast induced nephropathy in patients undergoing coronary angiography. 
Methods: In 244 patients undergoing coronary angiography we analyzed the association 
between systemic markers of inflammation (high sensitivity C-reactive protein, CRP) and 
contrast Induced nephropathy (GIN) defined as decrease in creatinine clearance (CC) of 
al least 25 cclmin. Univariate and multivariate analysis were performed. 
Results: Mean age of the patients was 62+13 yrs and 61% we males. Baseline CC was 
89 cclmin. 82% underwent angiography for acute coronary syndrome. 8% developed 
CIN following the angiography. 2% of the patients in the first tertile of CRP develped CIN 
compared to 12% in second and 13% in the third tertile of CRP, p=O.O3. On multivariate 
analysis higher CRP tertile was an independent predictor of CIN (OR 2.8, p=O.OZ) along 
with use of intra-aortic balloon pump (OR=9.3, p=O.O4) and baseline creatinine clearance 
(OR=1.04, p<O.OOOl). 
Conclusion: These findings demonstrate a strong association between the presence and 
magnitude of systemic inflammation and development of contrast induced nephropathy. 
1200-l 42 Stabilization of Plaque Size Accompanied by a Time 
Dependent Decrease in Activated Macrophage Content 
After Vascular Injury in the Apolipoprotein-E Null 
Mouse 
Christopher J. Davis, Joshua J. Fischer, John M. Sanders, Daniel K. Bennett, Ian J. 
Sarembock, University of Virginia Health System, Charlottesville, VA 
Background: Apolipoprotein-E knockout (ApoE’) mouse models have been used to 
study atherosclerosis and responses to vascular injury. Wire injury of the carotid artery 
results in characteristic neointima formation 28 days after injury. The purpose of this 
study was to characterize plaque size and cellular content at 2 and 3 months after carotid 
injury to identify changes in lesion progression. 
Methods: Sixteen female ApoE-‘- mice were fed a Western diet for one week prior to 
wire denudation of the left common carotid artery and continued on the atherogenic diet 
for 4 weeks. After 4 weeks, they were fed a chow diet until sacrifice. Mice were eutha- 
nized at 2 months (n=8) and 3 months (n=8) after injuty and fasting blood was taken for 
glucose and cholesterol measurements. Vessels were harvested and paraffin embedded 
for morphology and immunocytochemistry. The results were compared to 1 month histor- 
ical controls. 
Results: At 1 month, plaque size was 30,500 * 5,300 pm2 , macrophage content was 
21+ 5 %. and cholesterol level was 1170 r 210 mg/dl. At 2 and 3 months, neolntimal 
areas were not statistically different (35,177 * 6,789pd vs. 29.196 * 7,31 2pm2 respec- 
tively) and similar to the 1 month group. The presence of activated macrophages in the 
neointima was significantly higher at 2 months compared to 3 months (26.2 f 5.7 % Vs 
4.2 * 1.5 %. p = ,002). There were no significant differences in mean glucose and choles- 
terol levels at 2 and 3 months (107 * 7 vs. 108 * 11 mg/dl and 427 * 20 vs. 435 * 35 mg/ 
dl respectively). 
